T
204.74
-3.54 (-1.70%)
| Previous Close | 208.29 |
| Open | 198.88 |
| Volume | 61,891 |
| Avg. Volume (3M) | 990,427 |
| Market Cap | 18,088,984,576 |
| Price / Earnings (TTM) | 13.93 |
| Price / Earnings (Forward) | 12.87 |
| Price / Sales | 0.900 |
| Price / Book | 4.41 |
| 52 Weeks Range | |
| Earnings Date | 28 Oct 2025 |
| Profit Margin | 7.18% |
| Operating Margin (TTM) | 16.16% |
| Diluted EPS (TTM) | 15.91 |
| Quarterly Revenue Growth (YOY) | 3.30% |
| Quarterly Earnings Growth (YOY) | 11.20% |
| Total Debt/Equity (MRQ) | 158.70% |
| Current Ratio (MRQ) | 1.71 |
| Operating Cash Flow (TTM) | 2.46 B |
| Levered Free Cash Flow (TTM) | 899.88 M |
| Return on Assets (TTM) | 7.63% |
| Return on Equity (TTM) | 29.65% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | Tenet Healthcare Corporation | Bearish | Bullish |
AIStockmoo Score
0.5
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.0 |
| Average | 0.50 |
|
Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 50 as of July 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Mid Core |
| % Held by Insiders | 0.73% |
| % Held by Institutions | 98.94% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 260.00 (UBS, 26.99%) | Buy |
| Median | 240.00 (17.22%) | |
| Low | 225.00 (Mizuho, 9.90%) | Buy |
| Average | 240.80 (17.61%) | |
| Total | 10 Buy | |
| Avg. Price @ Call | 203.58 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| TD Cowen | 07 Jan 2026 | 230.00 (12.34%) | Buy | 202.00 |
| Wells Fargo | 07 Jan 2026 | 229.00 (11.85%) | Buy | 202.00 |
| 13 Nov 2025 | 252.00 (23.08%) | Buy | 196.66 | |
| Guggenheim | 02 Dec 2025 | 257.00 (25.53%) | Buy | 214.84 |
| 29 Oct 2025 | 238.00 (16.24%) | Buy | 209.14 | |
| Barclays | 21 Nov 2025 | 240.00 (17.22%) | Buy | 191.96 |
| JP Morgan | 13 Nov 2025 | 230.00 (12.34%) | Buy | 196.66 |
| Truist Securities | 03 Nov 2025 | 240.00 (17.22%) | Buy | 201.39 |
| RBC Capital | 30 Oct 2025 | 252.00 (23.08%) | Buy | 208.62 |
| Cantor Fitzgerald | 29 Oct 2025 | 245.00 (19.66%) | Buy | 209.14 |
| UBS | 29 Oct 2025 | 260.00 (26.99%) | Buy | 209.14 |
| Mizuho | 17 Oct 2025 | 225.00 (9.90%) | Buy | 200.00 |
| Show more | ||||
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 07 Jan 2026 | Announcement | Tenet to Report its Fourth Quarter 2025 Results on February 11th |
| 03 Nov 2025 | Announcement | Tenet Announces Upsizing and Pricing of Its $2.25 Billion Private Offerings of Senior Secured Notes and Senior Notes |
| 03 Nov 2025 | Announcement | Tenet Announces Private Offerings of Senior Secured Notes and Senior Notes to Refinance $2.0 Billion in Outstanding Notes |
| 28 Oct 2025 | Announcement | Tenet Reports Strong Third Quarter 2025 Results; Raises 2025 Financial Outlook |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 13 Mar 2000 | 06 Mar 2000 | 24 Mar 2000 | 0.01 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2000 | 0.010 | 1 | 0.01 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |